Large-scale testing (Phase 3)Study completedNCT01662882
What this trial is testing
A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
Avid Radiopharmaceuticals 48